comparemela.com

Latest Breaking News On - குறி ஃபிட்ஸ்‌ப்யாட்ரிக் - Page 14 : comparemela.com

The Takeaway: Timing of return to nuclear deal depends on Iran

Who s next? - Nuclear proliferation is not fast, but it is frightening | Briefing

Who’s next? Experts worry about East Asia and the Middle East I N MARCH 1963 President John Kennedy lamented his failure to negotiate a ban on nuclear tests. “Personally,” he warned, “I am haunted by the feeling that by 1970, unless we are successful, there may be ten nuclear powers instead of four and by 1975, 15 or 20.” Listen to this story Enjoy more audio and podcasts oniOSorAndroid. Kennedy was wrong. While many countries explored the idea of nuclear weapons from the 1950s to the 1990s, comparatively few took the next step of actually trying to develop the ability to build them (see chart). Of those few some stopped because the country itself dissolved (Yugoslavia), some because of changes to domestic politics (Brazil), some because of pressure from allies (South Korea) and some through force of arms (Iraq).

Chutes & Ladders—GSK vaccine exec Reichman splits to take biotech CEO post

(Pixabay)                  Welcome to this week s Chutes & Ladders, our roundup of hirings, firings and retirings throughout the industry. Please send the good word or the bad from your shop to Fraiser Kansteiner, and we will feature it here at the end of each week. Another GSK vaccine exec jumps ship for biotech CEO role GlaxoSmithKline Amir Reichman is stepping down. Reichman is leaving his post as head of global vaccines engineering core technology at GSK to eventually head up operations at BiondVax Pharmaceuticals. Reichman will split duties with BiondVax’s founder and CEO Ron Babecoff until March 2 as he wraps his time at GSK. Reichman joined GSK in 2015 as part of a multibillion-dollar deal that saw GSK trade off its oncology assets for Novartis’ vaccines unit. Reichman held various positions at Novartis in its vaccine supply chain unit before becoming director of GSK’s global vaccines supply chain and then head of global vaccines engineering

Why Iran s nuclear facilities are still vulnerable to attack

news Why Iran’s nuclear facilities are still vulnerable to attack The end of the Trump era has caused a collective but cautious sigh of relief in Iran. Some in the Gulf region feared that in the dying days of his presidency Donald Trump might choose to double down on his policy of maximum pressure on Iran and launch a military strike on its civilian nuclear plants and other targets. © EPA Iran has invested heavily in developing its surface-to-air missile to defend against air attack Reports from Washington in November indicated this was one option the US president had looked at, before being talked out of it by his advisers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.